Vanda Pharmaceuticals


Vanda Pharmaceuticals Stock Quote
$16.73 -$0.25 -1.5%
BATS BZX Real Time Price as of December 13, 2019, 4:00 p.m. EST View Interactive VNDA Charts

A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates, with exclusive worldwide commercial rights to three product candidates in clinical development for various central nervous system disorders.

News & Analysis: Vanda Pharmaceuticals

The Fool has written over 100 articles on Vanda Pharmaceuticals.


Market Moves


2 Top Stocks You Can Buy on Sale

The S&P 500 has rarely been more expensive than it is today. That doesn't mean bargain-hunting investors are out of luck.

3 High-Growth Stocks That Could Soar

This high-octane midstream stock, drug developer, and retail giant have the growth potential to send their shares skyward.

2 Top Stocks to Buy in March

Two down-on-their-luck growth stocks are worth a closer look after a poor start to 2019.

3 Top Growth Stocks to Buy Right Now

Investors looking to inject growth into their portfolios should give these companies a closer look.

Interactive Chart